Tom Lanz (Senior Director, Multi-Omics and Biomarkers, Pfizer) explains how AI-powered multi-omics is improving drug safety.
Check out the latest life sciences news in this edition of Week in Brief, where you can learn about all the biggest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results